Tag: president

HAVERTOWN, Pa., July 25, 2025 (GLOBE NEWSWIRE) -- AMREP Corporation (NYSE:AXR) today reported net income of $12,716,000, or $2.37 per diluted share, for its 2025 fiscal year ended April 30, 2025 compared to net income of $6,690,000, or $1.25 per diluted share, for the same period of the prior year. Revenues were $49,694,000 for fiscal 2025 and $51,369,000 for fiscal 2024.

WASHINGTON, July 25, 2025 (GLOBE NEWSWIRE) -- EB5 Capital is pleased to announce the first individual I-526E petition approval for an investor in its Charlotte Eagle Lake (JF42) project. An I-526E approval is a significant step in the EB-5 immigration process as it qualifies the investor and their eligible family members for conditional permanent residency in the United States. The approved petition was filed in January 2025 and was pending for approximately six months.

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- The Ontario Real Estate Association (OREA) Board of Directors is pleased to announce the appointment of Luigi Favaro as its new Chief Executive Officer (CEO), effective September 2, 2025. In this role, Favaro will lead the organization in its continued efforts to advocate on behalf of nearly 100,000 REALTOR® Members and support them in their pursuit of building stronger communities across the province.

NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- The ADVERTISING Club of New York, the industry's leading professional organization representing the advertising, media, marketing, and ad-tech industries is pleased to announce the appointment of five individuals to its Board of Directors. These appointments bring a wealth of experience and expertise to the organization as they rally around the mission to continue to educate, celebrate, and empower the industry.

COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year clinical efficacy data from its phase 2 trial with lead compound EVX-01 at the European Society for Medical Oncology (ESMO) Congress 2025 to be held in Berlin, Germany, from October 17-21, 2025.